PeptideStack
5.2kquestions
20kanswers
220users

What does a sampling plan on an ERP report change about how I read it?

Asked 15 Sept 2024Modified 18 months agoViewed 18k times
12

What I have: sampling plan · ERP.

I can parse the result. I am less sure what it licenses me to conclude.

I have deliberately not looked at anyone else’s interpretation yet.

What is the correct interpretation, and what is the common misreading?

coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

436 questions
shareeditfollowflag
CR
askedcoring_risk17k1815 Sept 2024

5 Answers

Sorted by votes
27

Before anything else, check that the lot number on the certificate matches the vial in your hand — that traces back to your material and not to some other lot from some other date.

Writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.

The certificate is a snapshot and nothing else — it tells you about the material on one day from one sample of one lot, and extrapolation beyond that requires logic.

Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.

The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.

shareimprove this answerflag
FV
answeredfill_volume13k1830 Nov 2024
4Do you have a reference for the last claim? Not disputing it, just want to read it. – tandem_gradient 6 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
19

A certificate without a method section is giving you a claim rather than a measurement, and claims are not evidence.

Test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.

Worth being precise here: comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.

Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.

Be careful not to over-read this — a certificate that is imperfect is not worthless, it is just a starting point for thought rather than an endpoint.

If the certificate does not trace to your vial, it is not evidence about your vial.

shareimprove this answerflag
TM
answeredtobias_maartens94k25819 Nov 2024
4This is the first explanation of that which has actually made sense to me. – greta_holzmann 3 months ago
5Note that the label instructions differ between agents on precisely this point. – micron22 5 months ago
add a comment
16

It helps to be literal here: what a useful certificate carries is debatable, but there are certain fields that almost no research-grade certificate includes despite their being standard in pharmaceutical work.

The test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.

The relevant detail is that batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.

Pharmacopoeial standards require method validation steps that research-grade certificates almost never claim to meet, and the absence of that claim is itself information.

My working rule is that a document without a lot number, a method section and a test date is marketing.

edited 14 Jan 2025 by k_szabo — reworded for clarity after a comment

shareimprove this answerflag
KS
answeredk_szabo45k3823 Dec 2024
13

The relevant detail is that the most common trap is reading a certificate as if it were a guarantee when it is actually a single point estimate from a single test.

Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.

The caveat is that a certificate is not a guarantee, it is a data point, and treating it as anything else is asking for disappointment.

The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.

edited 15 Dec 2024 by esben_lykke — added the method parameters

shareimprove this answerflag
EL
answeredesben_lykke15k2812 Dec 2024
12

The underlying point is that ask whether the certificate answers the question you are actually asking, because the answer is often no.

A purity figure to two decimal places with no supporting chromatogram is giving false precision and is a red flag on the same level as spelling errors.

Industry guidance on this topic is consistent because it comes from first principles rather than convention.

One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.

If the certificate does not trace to your vial, it is not evidence about your vial.

shareimprove this answerflag
VI
answeredvialroom87k14817 Oct 2024

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.